Navigation Links
Novus Biologicals Offers Webinar Discussing the Application of Combined RNA to Unravel Tumor Heterogeneity in Prostate Cancer
Date:3/17/2017

Ranking as the third leading cause of cancer death in American men, prostate cancer is a complex disease with multiple tumors originating independently at different stages of growth. Despite the identification of key morphological differences between individual tumor foci, the underlying molecular mechanisms driving growth within individual foci are often poorly understood.

This misunderstanding stems from the fact that the traditional molecular and genetic studies involving systemic sampling of large tumor foci or high Gleason grade tumor foci often miss small tumor foci with important driver aberrations and high metastatic potential. To avoid overlooking foci with important driver aberrations, well-characterized cancer-specific markers can be used to screen the entire prostate tissue to assess molecular differences in individual tumor foci.

In this presentation, sponsored by Novus Biologicals, participants will see a demonstration of the power of dual immunohistochemistry (IHC) and in situ hybridization (ISH) as a technique to probe multiple cancer-specific molecular markers in the morphological context. Webinar attendees will discover a clearer understanding of tumor heterogeneity and proper methods of applying dual IHC/ISH.

The team at Novus Biologicals has arranged two speakers to present during this webinar, Dr. Nallasivam Palanisamy, associate scientist with Henry Ford Health System and Dr. Courtney Anderson, senior scientist of R&D at Advanced Cell Diagnostics.

Palanisamy completed his graduate studies at the University of Madras in India, receiving a doctorate in human genetics. He was the founding director of R&D at the Cancer Genetics, Inc (CGIX), where he introduced new approaches to develop diagnostic reagents targeting chromosomal translocations in cancer. He currently serves as an associate senior scientist at the Henry Ford Health System, where his current research program is focused on the discovery of cancer biomarkers in lymphomas and solid cancers.

Anderson received her Ph.D. in molecular and developmental biology from the University of California San Francisco and her B.A. in human biology from Brown University. In her current role as a senior scientist in R&D at Advanced Cell Diagnostics, she manages numerous projects with collaborators from around the globe to demonstrate new and exciting applications of the RNAscope and BaseScope technologies and their ability to detect RNA biomarkers with single-molecule sensitivity and single-cell resolution with morphological context.

LabRoots will host the webinar March 21, 2017, beginning at 10:00 a.m. PT, 1:00 p.m. ET. To read more about this event and the speakers, learn about P.A.C.E. and Florida Continuing Education credits offered, or to register for free, click here.

ABOUT NOVUS BIOLOGICALS
Novus Biologicals®, a Bio-Techne brand, accelerates scientific discovery by developing and marketing unique products in the forefront of science. Novus Biologicals provides primary antibodies, secondary antibodies, conjugated antibodies and proteins to the bioscience community. All of its products are 100% guaranteed to conform to the application claims listed on the datasheet. Novus Biologicals is committed to innovation and has formed and will continue to form ongoing partnerships with leading researchers. For more information visit http://www.novusbio.com.

ABOUT LABROOTS
LabRoots is the leading scientific social networking website and producer of educational virtual events and webinars. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.

Read the full story at http://www.prweb.com/releases/2017/03/prweb14155783.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Youth Opioid Poisonings Up 165%; Novus Medical Detox Center Alerts Public to Leftover Painkillers
2. Over 168,000 Healthcare Workers Use Illicit Drugs, Warns Novus Medical Detox Center
3. Surgeon General Reports 20.8M Americans Misuse Drugs; Novus Medical Detox Center Analyzes Costs
4. Prescription Painkiller Use Surpasses Tobacco; Novus Medical Detox Center Analyzes Implications
5. Substance Abuse a Key Factor in Reduced Life Expectancy of White Americans, Warns Novus Medical Detox Center
6. Novus Medical Detox Center Says Regulating Sober Homes Will Benefit Residents and Communities
7. Novus Medical Detox Center Urges State Legislators to Regulate Opioid Prescribing and Dispensing
8. Novus Medical Detox Center Applauds CDC’s New Opioid Prescribing Guidelines but Calls for Additional Measures
9. Novus Medical Detox Center Cautions Patients to Beware of Prescription Medications Linked to Memory Loss
10. Prescription Drug Abuse Impacts 80% of Ind. Workplaces; Novus Medical Detox Center Advises Expanded Education
11. NH Voters Cite Drug Abuse as State’s Biggest Problem; Novus Medical Detox Center Urges Immediate Action
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... Pass, OR (PRWEB) , ... July 21, 2017 ... ... in recent weeks Nature’s Tears® EyeMist®, the signature product of her research center ... country with the world’s largest population and the greatest number of sufferers of ...
(Date:7/21/2017)... TORONTO, ONTARIO, CANADA (PRWEB) , ... July 21, ... ... with over 80% follow-up at 10 years, researchers from the Multicenter Orthopaedics Outcome ... knee-related quality of life a decade after surgery, though activity levels decline over ...
(Date:7/21/2017)... ... 21, 2017 , ... How physicians and athletic trainers assess ... researchers presenting their work at the American Orthopaedic Society for Sports Medicine’s ... the patterns of change in concussion symptom presentation, diagnostic tools used and length ...
(Date:7/20/2017)... ... , ... ChenMed , a leading provider of value-based care for seniors, ... as Richmond Chief Medical Officer. Dr. McCarter, formerly Associate Professor of Family Medicine ... Ambulatory Services for the UVA Health System, brings 30 years of highly relevant experience ...
(Date:7/20/2017)... July 20, 2017 (PRWEB) , ... ... ... Technologies, a global provider of enterprise-grade IT operations analytics and application performance ... of one of world’s largest healthcare services providers. , According to Peter ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... 11, 2017 Zymo Research Corp., also known as ,The Epigenetics ... biological aging in a precise manner using the myDNAge ™ test. ... a professor of human genetics and biostatistics at the David Geffen ... Health , Zymo Research,s proprietary DNAge ™ technology is used to ... ...
(Date:7/11/2017)... founder of Echenberg Institute, is announcing a new safe and effective at-home ... and other painful pelvic pain conditions such as pelvic floor dysfunction, vulvodynia, ... ... ... start-up company, VuVatech LLC, fills a void in the women,s wellness market ...
(Date:7/10/2017)... , July 10, 2017  BDI Group ... and patient support services organization serving specialty pharmacies, ... the launch of four significant, value-added member programs ... insights, better manage reimbursement and improve access and ... factor therapies. ...
Breaking Medicine Technology: